EMBC — Embecta Corp.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1872789 ·
Last close
$4.99
Market Cap
$282.73M
52W High
$5.62
52W Low
$3.01
ADV30
1,544,080
Next earnings
2026-08-07
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 271,700,000 | 153,300,000 | 64,300,000 | 21,100,000 | 1,265,300,000 | 214,700,000 | 1,878,000,000 |
| Mar 2026 | 221,800,000 | 127,800,000 | 42,900,000 | -4,100,000 | 1,029,300,000 | 184,900,000 | 1,655,400,000 |
| Dec 2025 | 261,200,000 | 161,700,000 | 76,300,000 | 44,100,000 | 1,063,700,000 | 201,300,000 | 1,676,800,000 |
| Sep 2025 | 264,000,000 | 158,500,000 | 64,300,000 | 26,400,000 | 1,090,900,000 | 225,500,000 | 1,742,100,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$213,500,000
Investing CF
$1,300,000
Financing CF
$-237,300,000
CapEx
$-8,800,000
Dividends Paid
$-35,300,000
Buybacks
—
EPS Diluted TTM
$1.90
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-424,700,000
Inventory
$192,600,000
Receivables
$147,100,000
ST Investments
—
EBIT TTM
$269,000,000
Pretax Income TTM
$169,600,000
Interest Exp TTM
$99,400,000
Analysts
2
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,018,700,032
EBITDA
$281,500,000
Free Cash Flow
$138,200,000
Enterprise Value
$1,583,329,664
Total Cash
$214,700,000
Total Debt
$1,501,699,968
Shares Out
56,659,599
Trailing EPS
$1.47
Book Value
$-10.81
ROE
—
ROA
12.2%
Div Yield
0.76%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Sep 2025 | 1,080,400,000 | 296,400,000 | 95,400,000 | 1,090,900,000 | 1,742,100,000 | — | 191,700,000 |
| Sep 2024 | 1,123,100,000 | 285,000,000 | 78,300,000 | 1,285,300,000 | 2,024,200,000 | — | 35,700,000 |
| Sep 2023 | 1,120,800,000 | 224,000,000 | 70,400,000 | 1,214,400,000 | 2,036,100,000 | — | 67,700,000 |
| Sep 2022 | 1,129,500,000 | 368,500,000 | 223,600,000 | 1,086,400,000 | 1,977,800,000 | — | 412,200,000 |
TTM Snapshot
Revenues TTM
$1,111,600,000
NetIncome TTM
$92,300,000
OpCashFlow TTM
$0
Assets (Latest)
$1,090,900,000
Forward EPS
$1.76
Max Pain — expiry 2026-11-20
max pain strike: $2.50 · spot: $4.99 · call oi: 1,249 · put oi: 300
Expected Move to 2026-11-20:
±$1.22
(24.55%) —
implied range
$3.76 –
$6.21
· ATM straddle on $5.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| TMCI | TREACE MEDICAL CONCEPTS, INC. | $284.20M | $4.37 | — |
| ANIK | Anika Therapeutics, Inc. | $285.59M | $21.34 | — |
| CV | CapsoVision, Inc | $291.77M | $5.83 | — |
| OSUR | ORASURE TECHNOLOGIES INC | $263.46M | $3.82 | — |
| RCEL | AVITA Medical, Inc. | $306.49M | $9.91 | — |
News headlines (Yahoo Finance, 1h cache)
Embecta (EMBC) Q3 2026 Earnings Call Transcript
2026-08-14 13:14 · Yahoo
Embecta Corp (EMBC) (Q3 2026) Earnings Call Highlights: Strong Sequential Recovery and Raised ...
2026-08-07 19:00 · Yahoo
Embecta Corp. Reports Third Quarter Fiscal 2026 Financial Results
2026-08-07 10:30 · Yahoo
Embecta (EMBC) Stock Fair Value Moves Lower As Analysts Reset Medtech Expectations
2026-07-15 06:08 · Yahoo
embecta to Participate in Investor Events
2026-06-01 21:00 · Yahoo
Embecta (EMBC) Hit With A Sharp Target Cut As Medtech Sentiment Weakens
2026-05-24 11:48 · Yahoo
Embecta acquires Owen Mumford for $172.6m
2026-05-18 11:13 · Yahoo
Embecta closes Owen Mumford acquisition for up to $201M
2026-05-18 11:10 · Yahoo
Embecta Faces U.S. Reset as CEO Bets on GLP-1, Owen Mumford Diversification
2026-05-16 16:06 · Yahoo
Embecta Corp. Q3 2026 Earnings Call Summary
2026-08-08 12:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.